(VIANEWS) – Universal Display Corporation (OLED), Palantir (PLTR), American Financial Group (AFG) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Universal Display Corporation (OLED)
20.2% sales growth and 14.91% return on equity
Universal Display Corporation engages in the research, development, and commercialization of organic light emitting diode (OLED) technologies and materials for use in display and solid-state lighting applications. It owns, exclusively licenses, or has sole rights to sublicense approximately 5,500 issued and pending patents worldwide. The company supplies its proprietary UniversalPHOLED materials to display and lighting manufacturers, and others. It is also involved in the research, development, and commercialization of other OLED device and manufacturing technologies, including FOLED that are flexible OLEDs for the fabrication of OLEDs on flexible substrates; OVJP, an organic vapor jet printing technology; thin-film encapsulation technology for the packaging of flexible OLEDs and other thin-film devices, as well as for use as a barrier film for plastic substrates; and UniversalP2OLED, which are printable phosphorescent OLEDs. In addition, the company provides technology development and support services, including third-party collaboration and support to third parties for the commercialization of their OLED products. Further, it provides contract research services in the areas of chemical materials synthesis research, development, and commercialization for non-OLED applications. Universal Display Corporation was founded in 1985 and is headquartered in Ewing, New Jersey.
Earnings Per Share
As for profitability, Universal Display Corporation has a trailing twelve months EPS of $4.24.
PE Ratio
Universal Display Corporation has a trailing twelve months price to earnings ratio of 39.13. Meaning, the purchaser of the share is investing $39.13 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.91%.
2. Palantir (PLTR)
17.2% sales growth and 5.44% return on equity
Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally. The company provides Palantir Gotham, a software platform which enables users to identify patterns hidden deep within datasets, ranging from signals intelligence sources to reports from confidential informants, as well as facilitates the handoff between analysts and operational users, helping operators plan and execute real-world responses to threats that have been identified within the platform. It also offers Palantir Foundry, a platform that transforms the ways organizations operate by creating a central operating system for their data; and allows individual users to integrate and analyze the data they need in one place. In addition, it provides Palantir Apollo, a software that delivers software and updates across the business, as well as enables customers to deploy their software virtually in any environment; and Palantir Artificial Intelligence Platform (AIP) that provides unified access to open-source, self-hosted, and commercial large language models (LLM) that can transform structured and unstructured data into LLM-understandable objects and can turn organizations' actions and processes into tools for humans and LLM-driven agents. The company was incorporated in 2003 and is headquartered in Denver, Colorado.
Earnings Per Share
As for profitability, Palantir has a trailing twelve months EPS of $0.09.
PE Ratio
Palantir has a trailing twelve months price to earnings ratio of 255.04. Meaning, the purchaser of the share is investing $255.04 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.44%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 75% and 40%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 16.8%, now sitting on 2.13B for the twelve trailing months.
Yearly Top and Bottom Value
Palantir’s stock is valued at $22.95 at 16:22 EST, higher than its 52-week high of $21.85.
3. American Financial Group (AFG)
15.6% sales growth and 20.5% return on equity
American Financial Group, Inc., an insurance holding company, provides property and casualty insurance products in the United States. The company operates through three segments: Property and Casualty Insurance, Annuity, and Other. It offers property and transportation insurance products, such as physical damage and liability coverage for buses, trucks, inland and ocean marine, agricultural-related products, and other commercial property coverages; specialty casualty insurance, including primarily excess and surplus, general liability, executive and professional liability, umbrella and excess liability, and specialty coverage in targeted markets, as well as customized programs for small to mid-sized businesses and workers' compensation insurance; and specialty financial insurance products comprising risk management insurance programs for lending and leasing institutions, surety and fidelity products, and trade credit insurance. The company sells its property and casualty insurance products through independent insurance agents and brokers, as well as through employee agents. It also provides traditional fixed, fixed-indexed, and variable-indexed annuities to the retail, financial institutions, registered investment advisor, and education markets. In addition, the company engages in the commercial real estate operations in Cincinnati, Whitefield, New Hampshire, Chesapeake Bay, Charleston, and Palm Beach. American Financial Group, Inc. was founded in 1872 and is headquartered in Cincinnati, Ohio.
Earnings Per Share
As for profitability, American Financial Group has a trailing twelve months EPS of $10.06.
PE Ratio
American Financial Group has a trailing twelve months price to earnings ratio of 13.45. Meaning, the purchaser of the share is investing $13.45 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.5%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8.7%, now sitting on 7.45B for the twelve trailing months.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Apr 12, 2024, the estimated forward annual dividend rate is 2.84 and the estimated forward annual dividend yield is 2.1%.
Moving Average
American Financial Group’s worth is above its 50-day moving average of $126.41 and way above its 200-day moving average of $117.68.
Sales Growth
American Financial Group’s sales growth is 19.5% for the present quarter and 15.6% for the next.
4. ANI Pharmaceuticals (ANIP)
13% sales growth and 4.72% return on equity
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Earnings Per Share
As for profitability, ANI Pharmaceuticals has a trailing twelve months EPS of $0.85.
PE Ratio
ANI Pharmaceuticals has a trailing twelve months price to earnings ratio of 81.55. Meaning, the purchaser of the share is investing $81.55 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.72%.
Moving Average
ANI Pharmaceuticals’s worth is way higher than its 50-day moving average of $59.65 and way above its 200-day moving average of $56.71.
Volume
Today’s last reported volume for ANI Pharmaceuticals is 168901 which is 24.83% above its average volume of 135300.
Revenue Growth
Year-on-year quarterly revenue growth grew by 39.7%, now sitting on 486.82M for the twelve trailing months.
Sales Growth
ANI Pharmaceuticals’s sales growth is 50.8% for the ongoing quarter and 13% for the next.
Previous days news about ANI Pharmaceuticals(ANIP)
- According to Zacks on Wednesday, 3 April, "Some better-ranked stocks in the overall healthcare sector include ADMA Biologics (ADMA Quick QuoteADMA – Free Report) , ANI Pharmaceuticals (ANIP Quick QuoteANIP – Free Report) and Ligand Pharmaceuticals (LGND Quick QuoteLGND – Free Report) ,each sporting a Zacks Rank #1 (Strong Buy) at present. ", "Earnings of ANI Pharmaceuticals beat estimates in each of the last four quarters. "
5. Pro-Dex (PDEX)
6.2% sales growth and 10.68% return on equity
Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.
Earnings Per Share
As for profitability, Pro-Dex has a trailing twelve months EPS of $0.84.
PE Ratio
Pro-Dex has a trailing twelve months price to earnings ratio of 20.41. Meaning, the purchaser of the share is investing $20.41 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.68%.
Moving Average
Pro-Dex’s value is below its 50-day moving average of $18.95 and under its 200-day moving average of $17.73.
6. Grand Canyon Education (LOPE)
6% sales growth and 30.24% return on equity
Grand Canyon Education, Inc. provides education services to colleges and universities in the United States. The company's technology services include learning management system, internal administration, infrastructure, and support services; academic services comprises program and curriculum, faculty and related training and development, class scheduling, and skills and simulation lab sites; and counseling services and support include admission, financial aid, and field experience and other counseling services. It also offers marketing and communication services, such as lead acquisition, digital communications strategy, brand identity, market research, media planning and strategy, video, and business intelligence and data science; and back-office services comprising finance and accounting, human resources, audit, and procurement services. The company supports healthcare education programs for 27 universities. Grand Canyon Education, Inc. was founded in 1949 and is based in Phoenix, Arizona.
Earnings Per Share
As for profitability, Grand Canyon Education has a trailing twelve months EPS of $6.8.
PE Ratio
Grand Canyon Education has a trailing twelve months price to earnings ratio of 19.6. Meaning, the purchaser of the share is investing $19.6 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 30.24%.
Sales Growth
Grand Canyon Education’s sales growth is 9% for the current quarter and 6% for the next.
Yearly Top and Bottom Value
Grand Canyon Education’s stock is valued at $133.30 at 16:22 EST, under its 52-week high of $144.94 and way above its 52-week low of $99.65.
